Julio Bobes Selected Research

Passive-Aggressive Personality Disorder (Personality Disorder, Passive Aggressive)

1/2010

[Open narcissism, covered narcissism and personality disorders as predictive factors of treatment response in an out-patient Drug Addiction Unit].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Bobes Research Topics

Disease

44	Schizophrenia (Dementia Praecox) 11/2022 - 09/2002
24	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 02/2007
8	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 05/2011
7	Mental Disorders (Mental Disorder) 01/2022 - 10/2009
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2018 - 02/2007
6	Borderline Personality Disorder (Personality Disorders, Borderline) 03/2021 - 01/2002
5	Cognitive Dysfunction 01/2020 - 09/2012
5	Alcoholism (Alcohol Abuse) 05/2014 - 07/2008
3	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2017
3	Substance-Related Disorders (Drug Abuse) 10/2021 - 12/2011
3	Opioid-Related Disorders (Opiate Addiction) 03/2021 - 02/2014
3	Weight Gain 10/2014 - 09/2002
3	Fibromyalgia (Fibrositis) 08/2014 - 01/2013
3	Coronary Disease (Coronary Heart Disease) 02/2013 - 02/2007
2	Genetic Risk Score 01/2022 - 01/2021
2	Drug Misuse 11/2021 - 12/2011
2	Hepatitis B 11/2021 - 12/2011
2	Anxiety Disorders (Anxiety Disorder) 03/2021 - 04/2010
2	Inflammation (Inflammations) 11/2020 - 01/2020
2	Obesity 01/2018 - 10/2014
2	Nausea 10/2016 - 04/2010
2	Pain (Aches) 08/2014 - 11/2013
2	Fatigue 08/2014 - 04/2010
2	Mania (Manias) 10/2012 - 10/2009
2	Hyperprolactinemia 07/2011 - 09/2002
2	Abdominal Obesity 02/2008 - 02/2007
1	Neurodevelopmental Disorders 01/2022
1	Psychotic Affective Disorders 01/2022
1	Hallucinations (Hallucination) 10/2021
1	Disease Progression 07/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2021
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 03/2021
1	Antisocial Personality Disorder (Antisocial Personality) 03/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2021
1	Gambling (Pathological Gambling) 03/2021
1	Mood Disorders (Mood Disorder) 11/2020
1	Panic Disorder (Panic Attack) 01/2020
1	Depressive Disorder (Melancholia) 01/2019
1	Hemolysis 07/2018
1	Infections 12/2017
1	Body Weight (Weight, Body) 10/2017

Drug/Important Bio-Agent (IBA)

23	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 09/2002
12	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 01/2017
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2015
6	Olanzapine (Zyprexa)FDA Link 01/2021 - 09/2002
6	Quetiapine Fumarate (Seroquel)FDA Link 01/2021 - 09/2002
5	Pharmaceutical PreparationsIBA 11/2021 - 04/2006
5	Biological ProductsIBA 10/2021 - 05/2002
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2022 - 10/2009
3	Methadone (Dolophine)FDA LinkGeneric 11/2021 - 02/2014
3	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2017 - 09/2002
3	ametantrone (HAQ)IBA 08/2014 - 01/2013
3	Naltrexone (ReVia)FDA LinkGeneric 01/2011 - 07/2008
3	Topiramate (Topamax)FDA LinkGeneric 01/2011 - 07/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 11/2021 - 12/2011
2	Heroin (Diamorphine)IBA 11/2021 - 12/2011
2	Opioid Analgesics (Opioids)IBA 03/2021 - 12/2017
2	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 10/2017
2	SolutionsIBA 11/2019 - 08/2015
2	Interleukin-2 (IL2)IBA 10/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 10/2019 - 07/2011
2	SmokeIBA 01/2019 - 06/2016
2	CytokinesIBA 01/2019 - 12/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2009
2	Haloperidol (Haldol)FDA LinkGeneric 09/2013 - 09/2002
2	Adenosine Triphosphate (ATP)IBA 12/2011 - 02/2008
2	Interleukin-1 (Interleukin 1)IBA 12/2009 - 09/2006
2	HDL CholesterolIBA 02/2008 - 02/2007
1	Sp4 Transcription FactorIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Methotrimeprazine (Levomepromazine)FDA Link 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2021
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 11/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	norclozapineIBA 01/2020
1	Biological FactorsIBA 10/2019
1	Retinaldehyde (Retinal)IBA 04/2019
1	InterleukinsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2018
1	AntioxidantsIBA 07/2018
1	CatalaseIBA 07/2018
1	HomocysteineIBA 07/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	E-SelectinIBA 01/2018
1	AdiponectinIBA 01/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 12/2017
1	Complement System Proteins (Complement)IBA 06/2017

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2017 - 11/2009
2	Therapeutics 12/2017 - 10/2012
2	Gluten-Free Diet 08/2014 - 11/2013
1	Opiate Substitution Treatment 03/2021
1	Length of Stay 02/2021
1	Immunomodulation 11/2020
1	Injections 01/2018